Clinically important interaction between statin drugs and Clostridium difficile toxin?

Medical Hypotheses

Volumn 73, Issue 6, 2009, Pages 1045-1047

  McGuire, Timothy ^a   Dobesh, Paul ^a   Klepser, Don ^a   Rupp, Mark ^b   Olsen, Keith ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; GLUCOSYLTRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE; RHO FACTOR; STEROID;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CELL CYCLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COLON MUCOSA; CONTROLLED STUDY; CYTOSKELETON; DATA ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; DRUG MECHANISM; DRUG USE; GERIATRIC PATIENT; HOSPITAL PATIENT; HUMAN; HYPOTHESIS; INCIDENCE; INFECTION RATE; INFECTION RISK; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN PRENYLATION; PUBLIC HEALTH; RETROSPECTIVE STUDY; RISK FACTOR; SIGNAL TRANSDUCTION; STOMACH ACID SECRETION;

AGED; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MODELS, THEORETICAL;

CLOSTRIDIUM DIFFICILE;

EID: 70449727756     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.06.058     Document Type: Article

References (15)

1. Kelly C.P., and LaMont J.T. Clostridium difficile - more difficult than ever. N Eng J Med 359 (2008) 1932-1940
2. Severe C. Clostridium difficile - associated disease in populations previously at low risk. MMWR Morb Mortal Wkly Rep 54 (2005) 1201-1205
3. Sutton P.A., Li S., Webb J., Solomon K., Brazier J., and Mahida Y.R. Essential role of toxin A in Clostridium difficile 027 and reference strain supernatant mediated disruption of Caco-2 intestinal epithelial barrier function. Clin Exp Immunol 153 (2008) 439-447
4. Dobesh P.P., Klepser D.G., McGuire T.R., Morgan C.W., and Olsen K.M. Statins associated with a reduction in mortality in patients with sepsis. Pharmacotherapy 29 (2009) 621-630
5. Aseeri M., Schroeder T., Kramer J., and Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostrium difficile associated diarrhea in hospitalized patients. Am J Gastroenterol 103 (2008) 2308-2313
6. Mann D., Reynolds K., Smith D., and Muntner P. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 national cholesterol education program guidelines. Ann Pharmacother 42 (2008) 1208-1215
7. Ridker P.M., Danielson E., Francisco A.H., Genest J., Gotto A.M., Kastelein J., et al. For the JUPITER study group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Eng J Med 359 (2008) 2195-2207
8. Glynn R.J., Danielson E., Fonseca F., Genest J., Gotto A.M., Kastelein J., et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Eng J Med 360 (2009) 1851-1861
9. Falagas M.E., Makris G.C., Matthaiou D.K., and Rafailidis P.I. Statins for infection and sepsis: a systematic review of clinical evidence. J Antimicrob Chem 61 (2008) 774-785
10. Jank T., Giesmann T., and Aktories K. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17 (2007) 15R-22R
11. Agarwal B., Halmos B., Feoktiston A.S., Protiva P., Ramey W.G., Chen M., et al. Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells. Carcinogenesis 23 (2002) 521-528
12. Hookman P., and Barkin J.S. Clostribium difficile associated infection, diarrhea and colitis. World J Gastroenterol 15 (2009) 1554-1580
13. Lyerly D., Saum K.E., MacDonald D.K., and Wilkins T.D. Effects on Clostridium difficile toxins given intragastrically to animals. Infect Immun 47 (1985) 349-352
14. Wilson K.H., Sheagren J.N., and Freter R. Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J Infect Dis 151 (1985) 355-361
15. Aseeri M., Schroeder T., Kramer J., and Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostrium difficile associated diarrhea in hospitalized patients. Am J Gastroenterol 103 (2008) 2308-2313